US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...
Nasdaq25d
ARS Pharmaceuticals Presents Data On Neffy Epinephrine Nasal Spray At 2025 AAAAI Meeting
(RTTNews) - ARS Pharmaceuticals, Inc. (SPRY), a biopharmaceutical company ... the safety and efficacy of neffy or epinephrine nasal spray, the first FDA-approved needle-free treatment for Type ...